{"id":"https://openalex.org/W2145777529","doi":"https://doi.org/10.1007/s00125-012-2538-9","title":"Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study","display_name":"Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study","alternate_titles":[],"publication_year":2012,"publication_date":"2012-03-29","ids":{"openalex":"https://openalex.org/W2145777529","doi":"https://doi.org/10.1007/s00125-012-2538-9","mag":"2145777529","pmid":"https://pubmed.ncbi.nlm.nih.gov/22460763","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3369136"},"language":"en","primary_location":{"id":"doi:10.1007/s00125-012-2538-9","doi":"https://doi.org/10.1007/s00125-012-2538-9","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00125-012-2538-9","pdf_url":"https://link.springer.com/content/pdf/10.1007/s00125-012-2538-9.pdf","source":{"id":"https://openalex.org/S104375418","display_name":"Diabetologia","issn_l":"0012-186X","issn":["0012-186X","1432-0428"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetologia","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2145777529"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s00125-012-2538-9.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055912652","display_name":"Anke Neumann","orcid":"https://orcid.org/0000-0002-6697-8023","observed_orcids":["https://orcid.org/0000-0002-6697-8023"]},"institutions":[{"id":"https://openalex.org/I4210131891","display_name":"l'Assurance Maladie","ror":"https://ror.org/03am7sg53","country_code":"FR","type":"other","lineage":["https://openalex.org/I4210131891"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"A. Neumann","raw_affiliation_strings":["Caisse Nationale de l'Assurance Maladie, 50 Avenue du Pr Andr\u00e9 Lemierre, 75986 Paris Cedex 20, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Caisse Nationale de l'Assurance Maladie, 50 Avenue du Pr Andr\u00e9 Lemierre, 75986 Paris Cedex 20, France","institution_ids":["https://openalex.org/I4210131891"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080099253","display_name":"Alain Weill","orcid":"https://orcid.org/0000-0001-8687-9092","observed_orcids":["https://orcid.org/0000-0001-8687-9092"]},"institutions":[{"id":"https://openalex.org/I4210131891","display_name":"l'Assurance Maladie","ror":"https://ror.org/03am7sg53","country_code":"FR","type":"other","lineage":["https://openalex.org/I4210131891"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"A. Weill","raw_affiliation_strings":["Caisse Nationale de l\u2019Assurance Maladie, 50 Avenue du Pr Andr\u00e9 Lemierre, 75986, Paris Cedex 20, France","Caisse Nationale de l\u2019Assurance Maladie, Paris Cedex 20, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Caisse Nationale de l\u2019Assurance Maladie, 50 Avenue du Pr Andr\u00e9 Lemierre, 75986, Paris Cedex 20, France","institution_ids":["https://openalex.org/I4210131891"]},{"raw_affiliation_string":"Caisse Nationale de l\u2019Assurance Maladie, Paris Cedex 20, France","institution_ids":["https://openalex.org/I4210131891"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113589634","display_name":"Philippe Ricordeau","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131891","display_name":"l'Assurance Maladie","ror":"https://ror.org/03am7sg53","country_code":"FR","type":"other","lineage":["https://openalex.org/I4210131891"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"P. Ricordeau","raw_affiliation_strings":["Caisse Nationale de l\u2019Assurance Maladie, 50 Avenue du Pr Andr\u00e9 Lemierre, 75986, Paris Cedex 20, France","Caisse Nationale de l\u2019Assurance Maladie, Paris Cedex 20, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Caisse Nationale de l\u2019Assurance Maladie, 50 Avenue du Pr Andr\u00e9 Lemierre, 75986, Paris Cedex 20, France","institution_ids":["https://openalex.org/I4210131891"]},{"raw_affiliation_string":"Caisse Nationale de l\u2019Assurance Maladie, Paris Cedex 20, France","institution_ids":["https://openalex.org/I4210131891"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083634045","display_name":"Jean\u2010Paul Fagot","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131891","display_name":"l'Assurance Maladie","ror":"https://ror.org/03am7sg53","country_code":"FR","type":"other","lineage":["https://openalex.org/I4210131891"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"J. P. Fagot","raw_affiliation_strings":["Caisse Nationale de l\u2019Assurance Maladie, 50 Avenue du Pr Andr\u00e9 Lemierre, 75986, Paris Cedex 20, France","Caisse Nationale de l\u2019Assurance Maladie, Paris Cedex 20, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Caisse Nationale de l\u2019Assurance Maladie, 50 Avenue du Pr Andr\u00e9 Lemierre, 75986, Paris Cedex 20, France","institution_ids":["https://openalex.org/I4210131891"]},{"raw_affiliation_string":"Caisse Nationale de l\u2019Assurance Maladie, Paris Cedex 20, France","institution_ids":["https://openalex.org/I4210131891"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026413767","display_name":"Fran\u00e7ois Alla","orcid":"https://orcid.org/0000-0002-5793-7190","observed_orcids":["https://orcid.org/0000-0002-5793-7190"]},"institutions":[{"id":"https://openalex.org/I4210131891","display_name":"l'Assurance Maladie","ror":"https://ror.org/03am7sg53","country_code":"FR","type":"other","lineage":["https://openalex.org/I4210131891"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"F. Alla","raw_affiliation_strings":["Caisse Nationale de l\u2019Assurance Maladie, 50 Avenue du Pr Andr\u00e9 Lemierre, 75986, Paris Cedex 20, France","Caisse Nationale de l\u2019Assurance Maladie, Paris Cedex 20, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Caisse Nationale de l\u2019Assurance Maladie, 50 Avenue du Pr Andr\u00e9 Lemierre, 75986, Paris Cedex 20, France","institution_ids":["https://openalex.org/I4210131891"]},{"raw_affiliation_string":"Caisse Nationale de l\u2019Assurance Maladie, Paris Cedex 20, France","institution_ids":["https://openalex.org/I4210131891"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5088214034","display_name":"Hubert Allemand","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131891","display_name":"l'Assurance Maladie","ror":"https://ror.org/03am7sg53","country_code":"FR","type":"other","lineage":["https://openalex.org/I4210131891"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"H. Allemand","raw_affiliation_strings":["Caisse Nationale de l\u2019Assurance Maladie, 50 Avenue du Pr Andr\u00e9 Lemierre, 75986, Paris Cedex 20, France","Caisse Nationale de l\u2019Assurance Maladie, Paris Cedex 20, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Caisse Nationale de l\u2019Assurance Maladie, 50 Avenue du Pr Andr\u00e9 Lemierre, 75986, Paris Cedex 20, France","institution_ids":["https://openalex.org/I4210131891"]},{"raw_affiliation_string":"Caisse Nationale de l\u2019Assurance Maladie, Paris Cedex 20, France","institution_ids":["https://openalex.org/I4210131891"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5080099253"],"corresponding_institution_ids":["https://openalex.org/I4210131891"],"apc_list":{"value":3490,"currency":"USD","value_usd":3490},"apc_paid":{"value":3490,"currency":"USD","value_usd":3490},"fwci":14.7452,"has_fulltext":true,"cited_by_count":328,"citation_normalized_percentile":{"value":0.99566885,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":100},"biblio":{"volume":"55","issue":"7","first_page":"1953","last_page":"1962"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11339","display_name":"Metabolism, Diabetes, and Cancer","score":0.7728999853134155,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11339","display_name":"Metabolism, Diabetes, and Cancer","score":0.7728999853134155,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.11490000039339066,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.01510000042617321,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pioglitazone","display_name":"pioglitazone","score":1.0},{"id":"https://openalex.org/keywords/bladder-cancer","display_name":"bladder cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/diabetes-mellitus","display_name":"diabetes mellitus","score":0.8190000057220459},{"id":"https://openalex.org/keywords/drug-induced-cancer-risk","display_name":"drug-induced cancer risk","score":0.6539999842643738},{"id":"https://openalex.org/keywords/thiazolidinediones","display_name":"thiazolidinediones","score":0.9229999780654907},{"id":"https://openalex.org/keywords/antidiabetic-drugs","display_name":"antidiabetic drugs","score":0.9449999928474426},{"id":"https://openalex.org/keywords/dose-response-relationship","display_name":"dose-response relationship","score":0.7900000214576721},{"id":"https://openalex.org/keywords/duration-of-drug-exposure","display_name":"drug exposure duration","score":0.6990000009536743},{"id":"https://openalex.org/keywords/cancer-incidence","display_name":"cancer incidence","score":0.5889999866485596}],"concepts":[{"id":"https://openalex.org/C2778384471","wikidata":"https://www.wikidata.org/wiki/Q417765","display_name":"Pioglitazone","level":4,"score":0.9825900793075562},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8916679620742798},{"id":"https://openalex.org/C2780352672","wikidata":"https://www.wikidata.org/wiki/Q504775","display_name":"Bladder cancer","level":3,"score":0.7341989874839783},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.6848224997520447},{"id":"https://openalex.org/C2778527826","wikidata":"https://www.wikidata.org/wiki/Q1787017","display_name":"Cancer registry","level":3,"score":0.6390963792800903},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5506653785705566},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.549094557762146},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.5341445803642273},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5187997221946716},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.4892313480377197},{"id":"https://openalex.org/C88879693","wikidata":"https://www.wikidata.org/wiki/Q217690","display_name":"Cumulative incidence","level":3,"score":0.47704166173934937},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.468504935503006},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.4546218514442444},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.40582603216171265},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3513514995574951},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.20971378684043884},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.14754962921142578},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.09089720249176025},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077205","descriptor_name":"Pioglitazone","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001749","descriptor_name":"Urinary Bladder Neoplasms","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D001749","descriptor_name":"Urinary Bladder Neoplasms","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D001749","descriptor_name":"Urinary Bladder Neoplasms","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005602","descriptor_name":"France","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015994","descriptor_name":"Incidence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015999","descriptor_name":"Multivariate Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016016","descriptor_name":"Proportional Hazards Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045162","descriptor_name":"Thiazolidinediones","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D045162","descriptor_name":"Thiazolidinediones","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1007/s00125-012-2538-9","doi":"https://doi.org/10.1007/s00125-012-2538-9","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00125-012-2538-9","pdf_url":"https://link.springer.com/content/pdf/10.1007/s00125-012-2538-9.pdf","source":{"id":"https://openalex.org/S104375418","display_name":"Diabetologia","issn_l":"0012-186X","issn":["0012-186X","1432-0428"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetologia","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2381062","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3369136","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:22460763","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22460763","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetologia","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3369136","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3369136/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetologia","raw_type":"Text"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.957.7458","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.957.7458","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://europepmc.org/backend/ptpmcrender.fcgi?accid%3DPMC3369136%26blobtype%3Dpdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1007/s00125-012-2538-9","doi":"https://doi.org/10.1007/s00125-012-2538-9","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00125-012-2538-9","pdf_url":"https://link.springer.com/content/pdf/10.1007/s00125-012-2538-9.pdf","source":{"id":"https://openalex.org/S104375418","display_name":"Diabetologia","issn_l":"0012-186X","issn":["0012-186X","1432-0428"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetologia","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2145777529.pdf","grobid_xml":"https://content.openalex.org/works/W2145777529.grobid-xml"},"referenced_works_count":16,"referenced_works":["https://openalex.org/W1967398770","https://openalex.org/W1967431308","https://openalex.org/W1999225509","https://openalex.org/W2012167887","https://openalex.org/W2016895882","https://openalex.org/W2026967508","https://openalex.org/W2082597621","https://openalex.org/W2083929133","https://openalex.org/W2121264929","https://openalex.org/W2130469036","https://openalex.org/W2133228717","https://openalex.org/W2139341329","https://openalex.org/W2156370651","https://openalex.org/W2159969745","https://openalex.org/W2164960433","https://openalex.org/W2169214947"],"related_works":["https://openalex.org/W1991441696","https://openalex.org/W2019295381","https://openalex.org/W2029655516","https://openalex.org/W2069723602","https://openalex.org/W2325092926","https://openalex.org/W2284212734","https://openalex.org/W2121264929","https://openalex.org/W2080454912","https://openalex.org/W2507604320"],"abstract_inverted_index":{"AIMS/HYPOTHESIS:":[0],"Previous":[1],"studies":[2],"have":[3],"suggested":[4],"an":[5],"increased":[6,214,258],"risk":[7,215,259],"of":[8,34,117,126,159,169,233,247,260],"bladder":[9,24,118,127,170,196,261],"cancer":[10,25,119,128,171,197],"with":[11,53,130,195,211,257],"pioglitazone":[12,21,252],"exposure.":[13],"We":[14,165,206],"aimed":[15],"to":[16,72,91,147,163],"investigate":[17],"the":[18,37,54],"association":[19],"between":[20],"exposure":[22,95,146,191,234,253],"and":[23,102,145,175,184,230],"in":[26,83],"France.":[27],"METHODS:":[28],"This":[29],"cohort":[30,67,86,153,246],"study":[31],"involved":[32,136],"use":[33],"data":[35],"from":[36,250],"French":[38,55],"national":[39],"health":[40],"insurance":[41],"information":[42],"system":[43],"(Syst\u00e8me":[44],"National":[45],"d'Information":[46],"Inter-r\u00e9gimes":[47],"de":[48,60],"l'Assurance":[49],"Maladie;":[50],"SNIIRAM)":[51],"linked":[52],"hospital":[56],"discharge":[57,124],"database":[58],"(Programme":[59],"M\u00e9dicalisation":[61],"des":[62],"Syst\u00e8mes":[63],"d'Information;":[64],"PMSI).":[65],"The":[66,85,152],"included":[68,154],"patients":[69,174,249],"aged":[70],"40":[71],"79":[73],"years":[74],"who":[75],"filled":[76,106],"a":[77,80,99,112,123,137,208,212],"prescription":[78],"for":[79,89,142,216],"glucose-lowering":[81,149],"drug":[82],"2006.":[84],"was":[87,96,192,254],"followed":[88],"up":[90],"42":[92],"months.":[93],"Pioglitazone":[94,190],"modelled":[97],"as":[98],"time-dependent":[100],"variable":[101],"defined":[103],"by":[104,122],"having":[105],"at":[107],"least":[108],"two":[109],"prescriptions":[110],"over":[111],"6-month":[113],"period.":[114],"Incident":[115],"cases":[116,168],"were":[120,161,182],"identified":[121],"diagnosis":[125],"combined":[129],"specific":[131],"aggressive":[132],"treatment.":[133],"Statistical":[134],"analyses":[135],"multivariate":[138],"Cox":[139],"model":[140],"adjusted":[141,223,238],"age,":[143],"sex":[144],"other":[148],"drugs.":[150],"RESULTS:":[151],"1,491,060":[155],"diabetic":[156,248],"patients,":[157],"155,535":[158],"whom":[160],"exposed":[162,173],"pioglitazone.":[164],"found":[166],"175":[167],"among":[172,177],"1,841":[176],"non-exposed":[178],"patients.":[179],"Incidence":[180],"rates":[181],"49.4":[183],"42.8":[185],"per":[186],"100,000":[187],"person-years,":[188],"respectively.":[189],"significantly":[193,213,255],"associated":[194,256],"incidence":[198],"(adjusted":[199],"HR":[200,224,239],"1.22":[201],"[95%":[202,226],"CI":[203,227],"1.05,":[204],"1.43]).":[205],"observed":[207],"dose-effect":[209],"relationship,":[210],"high":[217],"cumulative":[218],"doses":[219],"(\u2265":[220,235],"28,000":[221],"mg,":[222],"1.75":[225],"1.22,":[228],"2.50])":[229],"long":[231],"duration":[232],"24":[236],"months,":[237],"1.36":[240],"[1.04,":[241],"1.79]).":[242],"CONCLUSIONS/INTERPRETATION:":[243],"In":[244],"this":[245],"France,":[251],"cancer.":[262]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2145777529","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":12},{"year":2021,"cited_by_count":12},{"year":2020,"cited_by_count":11},{"year":2019,"cited_by_count":16},{"year":2018,"cited_by_count":27},{"year":2017,"cited_by_count":32},{"year":2016,"cited_by_count":36},{"year":2015,"cited_by_count":33},{"year":2014,"cited_by_count":46},{"year":2013,"cited_by_count":53},{"year":2012,"cited_by_count":23}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
